Cytek Biosciences, Inc.
CTKB
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; andā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$4.22
Price-2.09%
-$0.09
1Y
Price
Market Cap
$544.982m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-8.1%
EBITDA Margin-10.5%
Net Profit Margin-8.7%
Free Cash Flow Margin-8.1%
EBITDA Margin-10.5%
Net Profit Margin-8.7%
Free Cash Flow MarginRevenue
$204.171m
-1.8%
1y CAGR+6.6%
3y CAGR+12.0%
5y CAGREarnings
-$74.003m
-113.0%
1y CAGR-211.4%
3y CAGR-162.1%
5y CAGREPS
-$0.58
-100.0%
1y CAGR-201.8%
3y CAGR-159.7%
5y CAGRBook Value
$327.644m
$449.113m
Assets$121.469m
Liabilities$36.327m
DebtDebt to Assets
8.1%
-1.9x
Debt to EBITDAFree Cash Flow
-$12.698m
-127.0%
1y CAGR+1562.9%
3y CAGR-929.8%
5y CAGRNo items found.
Press Releases
Statements and updates from the company